May 26, 2010
The cumulative incidence of non-AIDS-defining cancers (NADCs) is approaching that of AIDS-defining cancers among HIV patients in settings where antiretroviral therapy is common, according to a consortium of researchers. Their report will be presented at the 2010 American Society of Clinical Oncology Annual Meeting in Chicago June 4-8.
"We're seeing high rates of head and neck cancer, lung cancer, kidney cancer, liver cancer, and anal cancer," said John F. Deeken, the report's co-author and director of head and neck oncology at Georgetown University Medical Center. The study also found marked increases in Hodgkin's lymphoma.
"Even when we control for smoking, we see a higher rate than the general population," Deeken said. "We don't know why this is happening. We need to figure that out."
05.20.2010; Darryl Fears
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.